Solventum Q3 2026: organic sales fall 2.8%, adjusted EPS outlook raised
Solventum's quarter looks worse at the top line than it is, and better on adjusted earnings than the GAAP loss suggests. Sales fell 7.0% to $1.95 billion and organic sales fell 2.8%, but management pinned 630 bps of that on order timing around an ERP cutover. Adjusted EPS of $1.45 held up and the full-year outlook went up; the $12 million GAAP loss is mostly separation, restructuring and amortization noise.
1 · Expected vs. Actual
Free preview belowGAAP diluted EPS was -$0.07 versus $7.22 a year ago, but the prior-year figure contained a $1,518 million gain on the purification and filtration sale, making the comparison meaningless. Adjusted EPS of $1.45 fell 3.6% from $1.50, with adjusted operating margin of 19.9% versus 20.6%. The $1.52 per-share gap between GAAP and adjusted is amortization, restructuring, separation and litigation costs.
Sales of $1.95 billion fell 7.0% from $2.10 billion a year earlier, and organic sales fell 2.8%. Management attributes 630 bps of the organic decline to customers pulling orders forward into Q2 ahead of the ERP cutover, so underlying demand is better than the print. Nine-month organic growth of +2.9% is the more honest read.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-11-05
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.